Sagittarius Life Science Corp (TPEX:3205)
Taiwan · Delayed Price · Currency is TWD 62.10
+0.20 (0.32%)
Apr 17, 2026, 1:30 PM CST
Sagittarius Life Science Market Cap
Sagittarius Life Science has a market cap or net worth of 4.19 billion as of April 17, 2026. Its market cap has increased by 289.37% in one year.
Market Cap
4.19B
Enterprise Value
3.39B
Revenue
346.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
62.10
Market Cap Chart
Since May 2, 2006, Sagittarius Life Science's market cap has increased from 288.69M to 4.19B, an increase of 1,352.99%. That is a compound annual growth rate of 14.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 4.19B | 21.05% |
| Dec 31, 2025 | 3.47B | 233.24% |
| Dec 31, 2024 | 1.04B | -38.79% |
| Dec 29, 2023 | 1.70B | 28.26% |
| Dec 30, 2022 | 1.32B | 48.00% |
| Dec 30, 2021 | 895.00M | -19.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UnicoCell Biomed | 5.17B |
| OBI Pharma | 4.99B |
| Senhwa Biosciences | 4.88B |
| Pharmosa Biopharm | 4.76B |
| Formosa Pharmaceuticals | 4.60B |
| Medigen Biotechnology | 4.25B |
| ACRO Biomedical | 4.09B |
| Energenesis Biomedical CO.,LTD. | 4.06B |